Stockreport

Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag [Yahoo! Finance]

Candel Therapeutics, Inc.  (CADL) 
PDF candidate, CAN-2409, for the treatment of pancreatic ductal adenocarcinoma (PDAC). Shares of the company rallied 42.8% on Apr 12, following the news. The FDA grants th [Read more]